CLINICAL_TRIALS
trial_result
· 2021-08-09
Clinical Trial Update: ALPPS Combined With Tislelizumab in Liver Malignancy [Phase 2]
Summary
Phase 2 clinical trial update evaluating ALPPS combined with tislelizumab for liver malignant tumors; status not disclosed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fudan University | Conditions: Liver Malignant Tumors | Phase 2 | Status: UNKNOWN